Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Myomo (MYO) Operating Expenses (2016 - 2025)

Myomo filings provide 9 years of Operating Expenses readings, the most recent being $10.0 million for Q3 2025.

  • On a quarterly basis, Operating Expenses rose 26.02% to $10.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $39.6 million, a 51.87% increase, with the full-year FY2024 number at $29.4 million, up 37.26% from a year prior.
  • Operating Expenses hit $10.0 million in Q3 2025 for Myomo, down from $10.6 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $10.6 million in Q2 2025 to a low of $4.6 million in Q1 2021.
  • Median Operating Expenses over the past 5 years was $5.5 million (2023), compared with a mean of $6.5 million.
  • Biggest five-year swings in Operating Expenses: decreased 16.66% in 2022 and later soared 65.24% in 2025.
  • Myomo's Operating Expenses stood at $5.8 million in 2021, then decreased by 16.66% to $4.9 million in 2022, then increased by 14.02% to $5.5 million in 2023, then soared by 59.99% to $8.9 million in 2024, then increased by 12.41% to $10.0 million in 2025.
  • The last three reported values for Operating Expenses were $10.0 million (Q3 2025), $10.6 million (Q2 2025), and $10.1 million (Q1 2025) per Business Quant data.